Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Copanlisib (dihydrochloride)

Product Specifications

UNSPSC Description

Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is a potent, selective and ATP-competitive pan-class I PI3K inhibitor, with IC50s of 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ, respectively. Copanlisib dihydrochloride has more than 2,000-fold selectivity against other lipid and protein kinases, except for mTOR. Copanlisib dihydrochloride has superior antitumor activity[1].

Target Antigen

Apoptosis; PI3K

Type

Reference compound

Related Pathways

Apoptosis;PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/copanlisib-dihydrochloride.html

Solubility

DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 50 mg/mL (ultrasonic)

Smiles

O=C(C1=CN=C(N)N=C1)NC2=NC3=C(OC)C(OCCCN4CCOCC4)=CC=C3C5=NCCN25.[H]Cl.[H]Cl

Molecular Weight

553.44

References & Citations

[1]Liu N, et al. BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models. Mol Cancer Ther. 2013 Nov;12(11):2319-30.Front Oncol. 2022 Sep 8:12:944537.|Blood Adv. 2022 Jan 14;bloodadvances.2021005948.|Blood. 2019 Jan 3;133(1):70-80.|Breast Cancer Res Treat. 2020 Jan;179(2):337-347.|Cancer Discov. 2024 Aug 13.|Cancer Lett. 2021 Oct 13;S0304-3835(21)00520-6.|Carbohydr Polym. 2024 Feb 15, 326, 121637.|Cell Biosci. 2020 Feb 12;10:16.|Cell Biosci. 2022 Aug 2;12(1):122.|Cell Biosci. 2022 Dec 30;12(1):210.|Front Immunol. 2021 Oct 15;12:699478.|Front Oncol. 2021 Jul 13;11:704042.|Genes Dis. 1 July 2021.|J Clin Invest. 2021 Dec 15;131(24):e140436.|J Immunother Cancer. 2022 Mar;10(3):e003402.|J Oncol. 2022 Apr 29;2022:1515416.|Mol Cancer. 2023 Mar 30;22(1):64.|Mol Cancer. 2024 Sep 30;23(1):215.|Mol Carcinog. 2024 Apr 17|Mol Syst Biol. 2023 Dec 18.|Nat Cancer. 2024 Jul 11.|RSC Adv., 2019, 9, 6409-6418|Science. 2017 Dec 1;358(6367):eaan4368.|Theranostics. 2020 Jan 1;10(4):1531-1543.|Université de Lausanne. 2024 Feb 7.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-15346A/Copanlisib-dihydrochloride-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-15346A/Copanlisib-dihydrochloride-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

1402152-13-9

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

BTS1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
13578111 3 x 1.0 µg

BTS1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Ask
View Details
GALR3 (NM_003614) Human Tagged Lenti ORF Clone
RC220196L2 10 µg

GALR3 (NM_003614) Human Tagged Lenti ORF Clone

Ask
View Details
Anti Mouse CD162 Flow Cytometry Monoclonal Clone 4RA10 FITC Ready To Use 200 Tests
IRTAMSCD1624RA10CFITC200 200 Tests

Anti Mouse CD162 Flow Cytometry Monoclonal Clone 4RA10 FITC Ready To Use 200 Tests

Ask
View Details
MRC2 CRISPRa sgRNA lentivector (set of three targets)(Human)
30388121 3 x 1.0μg DNA

MRC2 CRISPRa sgRNA lentivector (set of three targets)(Human)

Ask
View Details
Human Rh Blood Group, D Antigen (RHD) ELISA Kit DIY Materials
MBS2089442-01 5x 96 Tests

Human Rh Blood Group, D Antigen (RHD) ELISA Kit DIY Materials

Ask
View Details
Human Rh Blood Group, D Antigen (RHD) ELISA Kit DIY Materials
MBS2089442-02 5x 96 Tests + MBS2089472 (Support Pack 2,5x 96 Tests)

Human Rh Blood Group, D Antigen (RHD) ELISA Kit DIY Materials

Ask
View Details